- JAMA Internal Medicine Peer Reviewers in 2024
- Nudging Clinicians to Promote Serious Illness Communication
- Medicare Competitive Bidding Program and the SOAR Act
- Patient-Centered Buprenorphine Dosing in the Fentanyl Era
- Appropriate Deprescribing and Payment in Hospice Dementia Care
- Statin Use and Hepatocellular Carcinoma Risk and Liver Fibrosis in Liver Disease
- Avoidable Mortality Across US States and High-Income Countries
- Mortality Among US Physicians and Other Health Care Workers
- Tolerance of Guideline-Directed Medical Therapy—Reply
- A Mother’s Goodbye
- Tolerance of Guideline-Directed Medical Therapy
- First, Do No Harm—A Career-Long Struggle With Iatrogenesis
- Integrating Buprenorphine Into Chronic Pain Treatment—Putting the Choice in VOICE
- Veterans Affairs Research Under Threat
- JAMA Internal Medicine —The Year in Review, 2024
Esprimi il gradimento a questo contenuto
[Totale voti: 1 Media: 5]
